A feasibility study evaluating the functional diffusion map as a predictive imaging biomarker for detection of treatment response in a patient with metastatic prostate cancer to the bone - Wikidata - awgldk - TriplyDB

A feasibility study evaluating the functional diffusion map as a predictive imaging biomarker for detection of treatment response in a patient with metastatic prostate cancer to the bone

A feasibility study evaluating the functional diffusion map as a predictive imaging biomarker for detection of treatment response in a patient with metastatic prostate cancer to the bone

http://www.wikidata.org/entity/Q31140219

about

Current Status of Hybrid PET/MRI in Oncologic Imaging Bone imaging in prostate cancer: the evolving roles of nuclear medicine and radiology Diffusion imaging for therapy response assessment of brain tumor Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS): features and potential applications in oncology.Neoplasia: the second decade.Diffusion MRI in early cancer therapeutic response assessment.Synergy between anti-CCL2 and docetaxel as determined by DW-MRI in a metastatic bone cancer model A feasibility study of parametric response map analysis of diffusion-weighted magnetic resonance imaging scans of head and neck cancer patients for providing early detection of therapeutic efficacy.Voxel-by-voxel functional diffusion mapping for early evaluation of breast cancer treatment Diffusion-weighted MRI for assessment of early cancer treatment response.Incremental value of magnetic resonance imaging in the advanced management of prostate cancer.Challenges in clinical prostate cancer: role of imaging.Predicting and monitoring cancer treatment response with diffusion-weighted MRI.Targeted therapies in renal cell cancer: recent developments in imaging Assessment of multiexponential diffusion features as MRI cancer therapy response metrics Early treatment response in non-small cell lung cancer patients using diffusion-weighted imaging and functional diffusion maps--a feasibility study Applications of molecular imaging.Prospective analysis of parametric response map-derived MRI biomarkers: identification of early and distinct glioma response patterns not predicted by standard radiographic assessment.Multi-site clinical evaluation of DW-MRI as a treatment response metric for breast cancer patients undergoing neoadjuvant chemotherapy Integrated multimodal imaging of dynamic bone-tumor alterations associated with metastatic prostate cancer.Differential microstructure and physiology of brain and bone metastases in a rat breast cancer model by diffusion and dynamic contrast enhanced MRI.Bony metastases: assessing response to therapy with whole-body diffusion MRI.Functional diffusion map as an early imaging biomarker for high-grade glioma: correlation with conventional radiologic response and overall survival.Physiologic MRI for assessment of response to therapy and prognosis in glioblastoma.The parametric response map is an imaging biomarker for early cancer treatment outcome.Parametric response mapping of CT images provides early detection of local bone loss in a rat model of osteoporosis.Functional diffusion map as an imaging predictor of functional outcome in patients with primary intracerebral haemorrhage.Semiautomated Workflow for Clinically Streamlined Glioma Parametric Response Mapping Intravoxel incoherent motion imaging of tumor microenvironment in locally advanced breast cancer.Serial MR diffusion to predict treatment response in high-grade pediatric brain tumors: a comparison of regional and voxel-based diffusion change metrics Diffusion-Weighted MRI as a Biomarker of Tumor Radiation Treatment Response Heterogeneity: A Comparative Study of Whole-Volume Histogram Analysis versus Voxel-Based Functional Diffusion Map Analysis The War on Cancer rages on.Diffusion-weighted MRI in abdominal oncology: clinical applications.The evolution of imaging in cancer: current state and future challenges.Tumor response assessments with diffusion and perfusion MRI.Geometric distortion correction in prostate diffusion-weighted MRI and its effect on quantitative apparent diffusion coefficient analysis.Imaging and evaluation of patients with high-risk prostate cancer.Non-Mono-Exponential Analysis of Diffusion-Weighted Imaging for Treatment Monitoring in Prostate Cancer Bone Metastases.Computer-aided Detection of Prostate Cancer with MRI: Technology and Applications.T(2)-weighted combined with diffusion-weighted images for evaluating prostatic transition zone tumors at 3 Tesla.

P2860

Q26825265-D977CECF-2371-4D6C-950E-97F7FF69214A Q28071705-45BC3BAE-7A12-416D-ABE7-9DCDD3585288 Q30437277-B371C131-CB7E-42F3-BFC0-F1CE1A6711CC Q30483058-7FC2183B-DF3E-4B64-9B5A-77596DEB0D24 Q30484000-C80CC9B3-D2FE-4972-B134-5E00FCC12F59 Q31037179-5E1ADE04-B488-46B3-A1B9-75E4C9CDF671 Q33414714-1E7F3563-028C-4455-B2E9-A402BB90486C Q33496147-28AFB01B-F414-4230-A532-3B76F93C6F94 Q33584285-38F570F3-6A42-4BE0-9D0D-1E78D2F4045B Q33588005-739E5699-052E-4192-9BE0-BD6485ABF48A Q33772524-D205FC9E-A65F-4143-BA46-E31B89297ACD Q33945133-6BEE8546-1F2D-4EEA-A16F-B5BE004FDC15 Q34052992-ED08A889-DE67-402D-A9B6-78EC6449E406 Q34088696-56BFD1D5-6667-4DC2-8781-D719C49039DC Q34249651-DD1637DB-18D7-4B81-A465-D0B44F8C7DF6 Q34302644-679A541C-31F0-4F72-B4C0-10226EF1A1F5 Q35082412-3A909461-0057-45DB-9598-BEA3851B30DD Q35115962-8F6858AE-16FC-4075-AEF7-D66FBA991332 Q35224703-C1862775-F992-44E2-8276-C74ED73B3036 Q35598954-1E2D065A-5425-4A1B-9CD7-521BF2CF56C6 Q35600833-F07D394F-243A-4B7C-BA94-A31FA3A93DC6 Q35697593-01450ECB-535F-4A2A-844F-F515B427E892 Q35698555-E88A9509-4AC9-4E7A-B622-060B28565F38 Q35771783-7671E6EB-2514-4BF0-A158-EA1EEA600740 Q35838767-E89A952F-97B2-4DA6-9220-A8EDDF8D5196 Q36019924-BC7DBFEA-2568-40CA-9188-A316774C9EB8 Q36294857-9375A7F4-6FE9-4373-B674-F814AB65A121 Q36305786-02BFC88C-638E-4AD2-BFF5-0EB12C80EB89 Q36407355-A3A073D9-4098-4153-B2C8-817030C97BE0 Q37021537-C42E5BE3-0491-4B92-8470-6CAA66D39DD4 Q37236015-70D34AC6-5C86-47B8-96C4-9BA3F79C7B99 Q37478602-F1288DE8-784F-4D2F-BF8A-CEDAF7A0B8AA Q37689666-ECD634DD-0C3C-47AE-A936-B63B34030AC1 Q37848518-D80FB4E5-AD6E-41E1-BED5-BBAB26ECEC8F Q37995577-0B403D66-B12A-47E5-83AB-056B4160884C Q38598175-3866D0B9-932D-49E4-AA59-8EE8F119735F Q38611187-32B302F6-B4F3-4659-8497-16BD10F18703 Q38671355-34A39ABC-596C-4DFC-8F9B-199A5D2B894F Q38822172-379DDDAF-4A9A-44A5-B8BF-433853354D88 Q39439451-C7C41F74-E86E-46B3-A3B2-188028395CFF

P2860

A feasibility study evaluating the functional diffusion map as a predictive imaging biomarker for detection of treatment response in a patient with metastatic prostate cancer to the bone

http://www.wikidata.org/entity/Q31140219

description

2007 nî lūn-bûn

@nan

2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

A feasibility study evaluating ...... ic prostate cancer to the bone

@ast

A feasibility study evaluating ...... ic prostate cancer to the bone

@en

type

label

A feasibility study evaluating ...... ic prostate cancer to the bone

@ast

A feasibility study evaluating ...... ic prostate cancer to the bone

@en

prefLabel

A feasibility study evaluating ...... ic prostate cancer to the bone

@ast

A feasibility study evaluating ...... ic prostate cancer to the bone

@en

P1433

Q31140219-ADECF7D1-39E5-4058-BF7D-EA18A871C508

P1476

Q31140219-8DE21BF5-E21F-4B0D-8DB3-985F994FB9A4

P2093

Q31140219-02135D13-A9F5-44FB-BF2D-2DEF1C550F17

Q31140219-04824464-C21D-49D7-8F54-DDA62DB4C57E

Q31140219-09487717-8B1E-4B2A-AFDE-CE3C8408FFF2

Q31140219-1FF2D819-C80D-4FC9-93B1-E1FD2BE2F393

Q31140219-458DD04D-448D-4137-BA25-E130161E08FB

Q31140219-66228CB5-F4E9-4483-8B41-FD8653D059A4

Q31140219-89E81DDA-D766-4D35-B915-4A61C710F380

Q31140219-CA0A6CD1-32E8-4BAA-B86C-D495DC74B098

Q31140219-E2DDCCAE-82A3-4161-9FEB-2003EAF6850A

P2860

Q31140219-090B1135-A20B-4B70-A071-8C6A5B51D72D

Q31140219-09CD732D-0311-4D97-95CD-BEE2D22C7CC9

Q31140219-0F683259-3F8C-443A-ACD3-7C6C6B100269

Q31140219-16373FD3-086F-4AE4-9B07-6DB3AC199536

Q31140219-1B588008-94FA-4405-9A29-4A7C1D46102D

Q31140219-1EEE59E9-EC56-4EFC-AC56-89646373CB55

Q31140219-20503BD4-8717-4F1A-9E9C-D2A831E127BB

Q31140219-208729F4-4313-4C71-9859-BA0D5AD0174E

Q31140219-2BB506B5-7A2E-4070-9BAF-A287CA37F8D3

Q31140219-326B3560-9985-41FB-ACE1-853C436435B7

P304

Q31140219-320BC249-59AB-45FE-8BC1-AB437FD89115

P31

Q31140219-5AA9F2C9-E753-4990-AB2F-648AFF075D0E

P356

Q31140219-096BF048-D2C7-4DAB-A46B-99F8DFCA3368

P433

Q31140219-33046236-BA6B-423E-A0D7-0CDB5F7D9D80

P478

Q31140219-DDE609AC-846C-44FE-A835-09A98218DA1D

P50

Q31140219-555213CF-677E-43A8-8C35-0A6A7A0C9CBC

Q31140219-EB6E59CA-98B8-4C3B-A83C-43FBA2175480

P577

Q31140219-36A2DF61-6E31-4632-9618-9E88B6C0E1EA

P5875

Q31140219-46AD87DF-2D26-44C9-9C37-90C913FF05A9

P698

Q31140219-CAF87385-A9EA-4EDA-B1CC-31C2F2E0775F

P921

Q31140219-4CC56CBD-F41A-4E3F-BE8A-67547E5A6E6D

Q31140219-96288226-402D-40BA-9FDD-98191F90716E

P932

Q31140219-A461B9C7-1384-4582-991C-3B54531644D1

P356

P1433

P1476

A feasibility study evaluating ...... ic prostate cancer to the bone

@en

P2093

Alnawaz Rehemtulla

http://www.w3.org/2001/XMLSchema#string

Brian D Ross

http://www.w3.org/2001/XMLSchema#string

Charles R Meyer

http://www.w3.org/2001/XMLSchema#string

Craig J Galban

http://www.w3.org/2001/XMLSchema#string

Deborah A Bradley

http://www.w3.org/2001/XMLSchema#string

Kuei C Lee

http://www.w3.org/2001/XMLSchema#string

Maha Hussain

http://www.w3.org/2001/XMLSchema#string

Thomas L Chenevert

http://www.w3.org/2001/XMLSchema#string

Timothy D Johnson

http://www.w3.org/2001/XMLSchema#string

P2860

MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer

Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy

Diffusion MRI detects early events in the response of a glioma model to the yeast cytosine deaminase gene therapy strategy.

Early increases in breast tumor xenograft water mobility in response to paclitaxel therapy detected by non-invasive diffusion magnetic resonance imaging

Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors.

Early response of prostate carcinoma xenografts to docetaxel chemotherapy monitored with diffusion MRI.

Diffusion MRI: a new strategy for assessment of cancer therapeutic efficacy.

P304

1003-1011

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1593/NEO.07954

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Jon A. Jacobson

Kenneth J. Pienta

P577

2007-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5763340

http://www.w3.org/2001/XMLSchema#string

P698

18084607

http://www.w3.org/2001/XMLSchema#string

P921

P932

2134897

http://www.w3.org/2001/XMLSchema#string